The Consolidated Appropriations Act of 2023, approved by Congress last December, enacted a one-time, eight-hour requirement for all DEA-registered practitioners on the treatment and management of opioid or other substance abuse disorders (SUD).
Beginning June 27, 2023, clinicians will be required to check a box on their online DEA registration form (Initial and Renewals) affirming they have completed the requirement. The deadline to complete the requirement is the date of a clinician’s next scheduled DEA license renewal (typically every three years). To allow for sufficient lead time, credentialing will be notifying practitioners with upcoming DEA renewals.
Meeting the requirement
Free, online options to meet the requirement are available from the American Medical Association and the New England Journal of Medicine. Past training on the treatment and management of patients with opioid or other SUDs count toward the requirement.
Some practitioners may have already satisfied the requirement, including:
- Practitioners who are board certified in addiction medicine or addiction psychiatry from the American Board of Medical Specialties, the American Board of Addiction Medicine, or the American Osteopathic Association.
- All practitioners who graduated in good standing from a medical (allopathic or osteopathic), dental, physician assistant, or advanced practice nursing school in the United States within five years of June 27, 2023, and successfully completed eight hours of training on managing patients with SUD, including appropriate clinical use of FDA approved drugs for treatment or safe pharmacologic management of dental pain and screening, brief intervention and referral for appropriate treatment of those at risk for developing SUD.
